TABLE 5.
ESBL-producing isolates and interpretive susceptibility results of cephalosporins and aztreonam reported by participating laboratoriesa
| Strain | Characteristic(s)b | Cefotaxime
|
Ceftriaxone
|
Ceftazidime
|
Cefepime
|
Aztreonam
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ref MIC | No. of laboratories reporting a result of:
|
Ref MIC | No. of laboratories reporting a result of:
|
Ref MIC | No. of laboratories reporting a result of:
|
Ref MIC | No. of laboratories reporting a result of:
|
Ref MIC | No. of laboratories reporting a result of:
|
||||||||||||
| S | I | R | S | I | R | S | I | R | S | I | R | S | I | R | |||||||
| E. coli RYC5H/99 | TEM-27 + TEM-1 | 0.5 | 16 | 3 | 31 | 0.5 | 8 | 4 | 16 | >512 | 0 | 0 | 50 | 1 | 14 | 4 | 32 | 256 | 1 | 4 | 42 |
| E. coli RYC97056888 | CTX-M-9 + TEM-1 | 8 | 3 | 2 | 45 | 16 | 0 | 4 | 22 | 0.5 | 23 | 1 | 26 | 4 | 13 | 6 | 31 | 1 | 20 | 2 | 26 |
| K. pneumoniae LB3 | SHV-5 + OprK35− | 8 | 5 | 4 | 41 | 4 | 2 | 6 | 19 | 128 | 0 | 2 | 48 | 1 | 11 | 5 | 34 | 128 | 1 | 0 | 46 |
| K. pneumoniae LB4 | SHV-5 + OmpK35−/36− | 128 | 1 | 2 | 47 | 64 | 0 | 2 | 25 | >512 | 1 | 0 | 49 | 32 | 4 | 3 | 43 | 512 | 1 | 0 | 45 |
| E. cloacae RYC97095983 I | AmpC + CTX-M-10 | 64 | 1 | 7 | 41 | 64 | 0 | 2 | 26 | 2 | 24 | 7 | 18 | 16 | 17 | 9 | 23 | 8 | 11 | 13 | 22 |
| E. cloacae RYC97095983 SDM | AmpC ↑ + CTX-M-10 | 256 | 1 | 0 | 48 | 256 | 0 | 0 | 27 | 64 | 1 | 0 | 48 | 32 | 6 | 5 | 38 | 64 | 1 | 0 | 45 |
Ref, reference; S, susceptible; I, intermediate; R, resistant. MICs are given in micrograms per milliliter.
↑, hyperproduction.